Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: AlphaGen and ArtBio Form China-US Radioligand Partnership

Week in Review: LianBio to Close Operations; Will Pay $528 Million to Shareholders

Week in Review: I-Mab Morphs into US-Only Company; Sells China Assets for $80 Million

Week in Review: Shanghai Inmagene Signs $230 Million Deal to Develop Two HutchMed Immunology Assets

Week in Review: Arrivent BioPharma Raises $175 Million in IPO for In-licensings from China

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital